Clinical trial results

RAE Health completed their first clinical study in 2016 ("Wearable sensor-based detection of stress and craving in patients during treatment for substance use disorders: A mixed methods study") in conjunction with UMASS and two outpatient-based substance abuse treatment facilities.  Through this study data was refined and an algorithm derived that was then patented for detection.

 

Highlighted results:

 

• 72.4% accuracy in detecting Stress vs. Craving events

• 83.9% accuracy in detecting Stress vs. No Stress events

• 80.5% accuracy in detecting Cravings vs. No Craving events

NIH funded clinical study :

RAE was awarded SBIR Phase I/II Fast Track in 2019.  Phase I was completed February 2021.

Recent updates:

SBIR Phase II and Clinical Trial scheduled for 2021

Current accuracy in stress detection is 87%

Patent # US10478066B2

FOLLOW RAE
  • Twitter Social Icon
  • Instagram
  • Facebook Social Icon

© 2020 RAE Health. All rights reserved. All trademarks referenced are trademarks of RAE Health. All other trademarks referenced are trademarks of their respective owners.